Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Egbert A van der Meulen

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Journal of Biopharmaceutical Statistics|June 1, 2005
Are we really that blind?Egbert A van der Meulen
European Urology Focus|November 25, 2018
Low-dose Desmopressin Orally Disintegrating Tablet: Suggested Clinically Meaningful Benefit in Patients with Nocturia Due to Nocturnal PolyuriaJeffrey P Weiss, Egbert A van der Meulen, Kristian Vinter Juul
The Journal of Urology|March 5, 2013
Efficacy and safety of low dose desmopressin orally disintegrating tablet in men with nocturia: results of a multicenter, randomized, double-blind, placebo controlled, parallel group studyJeffrey P Weiss, Sender Herschorn, Cerasela D Albei, et al.
The Journal of Urology|March 5, 2013
Efficacy and safety of low dose desmopressin orally disintegrating tablet in women with nocturia: results of a multicenter, randomized, double-blind, placebo controlled, parallel group studyPeter K Sand, Roger R Dmochowski, Jyotsna Reddy, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|February 12, 2010
Longitudinal analysis of the suicidal behaviour risk in short-term placebo-controlled studies of mirtazapine in major depressive disorderSiegfried Kasper, Stuart A Montgomery, Hans-Jürgen Möller, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Journal of Biopharmaceutical Statistics|June 1, 2005
Are we really that blind?Egbert A van der Meulen
European Urology Focus|November 25, 2018
Low-dose Desmopressin Orally Disintegrating Tablet: Suggested Clinically Meaningful Benefit in Patients with Nocturia Due to Nocturnal PolyuriaJeffrey P Weiss, Egbert A van der Meulen, Kristian Vinter Juul
The Journal of Urology|March 5, 2013
Efficacy and safety of low dose desmopressin orally disintegrating tablet in men with nocturia: results of a multicenter, randomized, double-blind, placebo controlled, parallel group studyJeffrey P Weiss, Sender Herschorn, Cerasela D Albei, et al.
The Journal of Urology|March 5, 2013
Efficacy and safety of low dose desmopressin orally disintegrating tablet in women with nocturia: results of a multicenter, randomized, double-blind, placebo controlled, parallel group studyPeter K Sand, Roger R Dmochowski, Jyotsna Reddy, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|February 12, 2010
Longitudinal analysis of the suicidal behaviour risk in short-term placebo-controlled studies of mirtazapine in major depressive disorderSiegfried Kasper, Stuart A Montgomery, Hans-Jürgen Möller, et al.
Pageof 1